149 related articles for article (PubMed ID: 1723511)
1. (+) 3-[3-hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: evidence for subtypes, in vivo.
Iyengar S; Wood PL; Mick SJ; Dilworth VM; Gray NM; Farah JM; Rao TS; Contreras PC
Neuropharmacology; 1991 Aug; 30(8):915-22. PubMed ID: 1723511
[TBL] [Abstract][Full Text] [Related]
2. Effects of sigma ligands on mouse cerebellar cyclic guanosine monophosphate (cGMP) levels in vivo: further evidence for a functional modulation of N-methyl-D-aspartate (NMDA) receptor complex-mediated events by sigma ligands.
Rao TS; Mick SJ; Cler JA; Emmett MR; Dilworth VM; Contreras PC; Gray NM; Wood PL; Iyengar S
Brain Res; 1991 Oct; 561(1):43-50. PubMed ID: 1686745
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of sigma ligands on the extracellular DOPAC level in rat frontal cortex and striatum.
Matsuno K; Matsunaga KH; Mita S
Neurochem Res; 1995 Feb; 20(2):233-8. PubMed ID: 7783846
[TBL] [Abstract][Full Text] [Related]
4. (+)-6,7-benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue.
Booth RG; Baldessarini RJ
Brain Res; 1991 Aug; 557(1-2):349-52. PubMed ID: 1684130
[TBL] [Abstract][Full Text] [Related]
5. Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors.
Iyengar S; Dilworth VM; Mick SJ; Contreras PC; Monahan JB; Rao TS; Wood PL
Brain Res; 1990 Aug; 524(2):322-6. PubMed ID: 1963339
[TBL] [Abstract][Full Text] [Related]
6. Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations.
Hjorth S; Clark D; Carlsson A
Life Sci; 1985 Aug; 37(7):673-84. PubMed ID: 2410756
[TBL] [Abstract][Full Text] [Related]
7. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
Singh L; Wong EH; Kesingland AC; Tricklebank MD
Br J Pharmacol; 1990 Jan; 99(1):145-51. PubMed ID: 2158832
[TBL] [Abstract][Full Text] [Related]
8. Effects of sigma receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat.
Gudelsky GA
Eur J Pharmacol; 1995 Nov; 286(3):223-8. PubMed ID: 8608783
[TBL] [Abstract][Full Text] [Related]
9. Regulation of [3H]dopamine release from rat striatal slices by sigma receptor ligands.
Gonzalez-Alvear GM; Werling LL
J Pharmacol Exp Ther; 1994 Oct; 271(1):212-9. PubMed ID: 7965717
[TBL] [Abstract][Full Text] [Related]
10. BMY-14802 reverses the reduction of striatal dopamine release induced by (+)-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine.
Kanzaki A; Okumura K; Ujike H; Tsuchida K; Akiyama K; Otsuki S
J Neural Transm Gen Sect; 1992; 90(2):137-44. PubMed ID: 1361127
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical characterization of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vivo.
Rao TS; Cler JA; Mick SJ; Dilworth VM; Contreras PC; Iyengar S; Wood PL
Neuropharmacology; 1990 Dec; 29(12):1191-7. PubMed ID: 1963476
[TBL] [Abstract][Full Text] [Related]
12. Sigma receptors modulate the hypothalamic-pituitary-adrenal (HPA) axis centrally: evidence for a functional interaction with NMDA receptors, in vivo.
Iyengar S; Mick S; Dilworth V; Michel J; Rao TS; Farah JM; Wood PL
Neuropharmacology; 1990 Mar; 29(3):299-303. PubMed ID: 2158003
[TBL] [Abstract][Full Text] [Related]
13. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
Karbon EW; Naper K; Pontecorvo MJ
Eur J Pharmacol; 1991 Jan; 193(1):21-7. PubMed ID: 1675607
[TBL] [Abstract][Full Text] [Related]
14. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
DeLander GE; Wahl JJ
Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
Largent BL; Gundlach AL; Snyder SH
J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
[TBL] [Abstract][Full Text] [Related]
16. Correlation between potentiation of neurogenic twitch contraction and benzomorphan sigma receptor binding potency in the mouse vas deferens.
Matsuno K; Senda T; Mita S
Eur J Pharmacol; 1993 Feb; 231(3):451-7. PubMed ID: 8449236
[TBL] [Abstract][Full Text] [Related]
17. Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors.
Carroll FI; Abraham P; Parham K; Bai X; Zhang X; Brine GA; Mascarella SW; Martin BR; May EL; Sauss C
J Med Chem; 1992 Jul; 35(15):2812-8. PubMed ID: 1322987
[TBL] [Abstract][Full Text] [Related]
18. Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the rat.
Gudelsky GA
J Neural Transm (Vienna); 1999; 106(9-10):849-56. PubMed ID: 10599867
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical interactions of competitive N-methyl-D-aspartate antagonists with dopaminergic neurotransmission and the cerebellar cyclic GMP system: functional evidence for a phasic glutamatergic control of the nigrostriatal dopaminergic pathway.
Rao TS; Cler JA; Mick SJ; Emmett MR; Farah JM; Contreras PC; Iyengar S; Wood PL
J Neurochem; 1991 Mar; 56(3):907-13. PubMed ID: 1847188
[TBL] [Abstract][Full Text] [Related]
20. Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.
Brent PJ
Psychopharmacology (Berl); 1991; 105(3):421-7. PubMed ID: 1686818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
